Triple Negative Breast Cancer tumours not even similar.

59 scientists have made a new discovery that will change the way deadly breast cancer is to be treated. The study is the largest genetic analysis of what were thought to be triple negative breast cancer tumours. All 59 scientists entered the lab believing to find a similar gene. When the tests came back, they had found that no two genomes were the same, nor even similar. Steven Jones, the co-author of the study, stated "Seeing these tumours at a molecular level has taught us we're dealing with a continuum of different types of breast cancer here, not just one". Triple negative breast cancer lacks surface cell receptors for estrogen, progesterone and herceptin and targets 16% of women who developed breast cancer and targets those under 40. Scientists consider it the most deadly form of breast cancer because modern drugs do not respond well to it. This experiment is a discovery based science because the scientist expected to find a similar gene, but instead found something even more impacting. This experiment affects humans in a grand scale. Now that we know how triple negative breast cancer tumours look like, they can understand how to treat them better and hopefully save lives.